Yiting Zhou

Yiting Zhou

Auto-generated profile, based on publicly available information

Yiting Zhou

Department of Intervention Therapy, The Affiliated Hospital of Jiangnan University, Wuxi, 214002, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Lung Cancer
Verified
Journal Article
Closed access
YLYangyang Liu
Yangyang Liu
DCDonglai Chen
Donglai Chen
XQXie Qiu
Xie Qiu
SDShanzhou Duan
Shanzhou Duan
YZYongsheng Zhang
Yongsheng Zhang
YCYongbing Chen
Yongbing Chen

4 September 2023 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
YZYiting Zhou
Yiting Zhou
JTJiajia Tian
Jiajia Tian
YZYi Zhu
Yi Zhu
YZYating Zhang
Yating Zhang
XZXudong Zhao
Xudong Zhao

3 May 2019 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
YZYiting Zhou
Yiting Zhou
RZRui Zhang
Rui Zhang
GWGuangli Wang
Guangli Wang
AWAili Wang
Aili Wang
CZChongke Zhong
Chongke Zhong
YZYonghong Zhang
Yonghong Zhang
Objective: To investigate the coexistence of hypertension and angiotensin II on the risk of coronary heart disease based on a prospective study in an Inner Mongolian population of China. Methods: The participants were categorized into four subgroups according to hypertension status and median of angiotensin II level. Incident coronary heart disease (CHD) was defined as study outcome. A cox proportional hazard model was used to compute hazard ratios (HRs) and 95% confidence intervals (CIs) of CHD across the four subgroups after adjusting for important confounding factors. Results: During average 9.2 years of follow-up, a total of 75 incident CHD cases were observed. The cumulative incidence rates of CHD among normotensives with angiotensin II ≤49 pg/mL, normotensives with angiotensin II >49 pg/mL, hypertensives with angiotensin II ≤49 pg/mL and hypertensives with angiotensin II >49 pg/mL were 1.76%, 1.50%, 4.71% and 5.62%, respectively (log-rank test, P < 0.001). Compared to the normotensives, the multivariable adjusted HRs (95% CI) of CHD with hypertensives and Ang II >49 pg/mL were 2.43(1.41-4.17) and 1.30(0.81-2.07), respectively. Furthermore, compared to normotensives with angiotensin II ≤49 pg/mL, the multivariate-adjusted HRs (95% CIs) of CHD for normotensives with angiotensin II >49 pg/mL, hypertensives with Angiotensin II ≤49 pg/mL and hypertensives with angiotensin II >49 pg/mL were 1.33(0.60-2.91), 2.35 (1.16-4.76) and 3.00(1.52-5.92), respectively (P for trend <0.05). The hypertensives with angiotensin II >49 pg/mL were at the highest risk of CHD. Conclusions: Hypertension not angiotensin II was an independent risk factor for incident CHD, but coexistence of both hypertension and high angiotensin II level further increased risk of incident CHD among the Inner Mongolians.